Wright State University

CORE Scholar
Browse all Theses and Dissertations

Theses and Dissertations

2018

Design of a Novel Tissue Culture System to Subject Aortic Tissue
to Multidirectional Bicuspid Aortic Valve Wall Shear Stress
Janet Liu
Wright State University

Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all
Part of the Mechanical Engineering Commons

Repository Citation
Liu, Janet, "Design of a Novel Tissue Culture System to Subject Aortic Tissue to Multidirectional Bicuspid
Aortic Valve Wall Shear Stress" (2018). Browse all Theses and Dissertations. 1941.
https://corescholar.libraries.wright.edu/etd_all/1941

This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE
Scholar. For more information, please contact library-corescholar@wright.edu.

DESIGN OF A NOVEL TISSUE CULTURE
SYSTEM TO SUBJECT AORTIC TISSUE TO
MULTIDIRECTIONAL BICUSPID AORTIC
VALVE WALL SHEAR STRESS

A Thesis Submitted in Partial Fulfillment
of the Requirements for the Degree of
Master of Science in Mechanical Engineering

By

JANET LIU
B.S., Wright State University, 2014

2018
Wright State University

COPYRIGHT BY
JANET LIU
2018

WRIGHT STATE UNIVERSITY
GRADUATE SCHOOL
April 20, 2018
I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY
SUPERVISION Janet Liu ENTITLED Design of a Novel Tissue Culture System to Subject
Aortic Tissue to Multidirectional Bicuspid Aortic Valve Wall Shear Stress BE
ACCEPTED IN PARTIAL FULLFILLMENT OF THE REQUIRMENT FOR DEGREE
OF Master of Science of Mechanical Engineering.
________________________________
Philippe Sucosky, Ph.D., F.A.H.A.
Thesis Director
________________________________
Joseph C. Slater, Ph.D., P.E.
Chair, Department of Mechanical and
Materials Engineering
Committee on final examination:
________________________________
Jaime E. Ramirez-Vick, Ph.D.
________________________________
Zifeng Yang, Ph.D.
________________________________
Barry Milligan, Ph.D.
Interim Dean of the Graduate School

ABSTRACT
Liu, Janet. M.S.M.E., Department of Mechanical & Materials Engineering, Wright State
University. 2018. Design of a Novel Tissue Culture System to Subject Aortic Tissue to
Multidirectional Bicuspid Aortic Valve Wall Shear Stress
Blood vessels experience complex hemodynamics marked by three-dimensionality and
pulsatility. Arterial endothelial cells interact with the characteristics of the fluid wall shear
stress (WSS) to maintain homeostasis or promote disease states. In particular, the bicuspid
aortic valve (BAV), a congenital heart valve anatomy consisting of two leaflets instead of
three, is associated with aortic complications presumably promoted by hemodynamic
abnormalities. While devices have been used to test this hypothesis, their capabilities are
limited to the generation of time-varying WSS magnitude in one direction. However, the
increased flow helicity generated by BAVs in the aorta is expected to result in increased
WSS multidirectionality. Therefore, the objectives of this thesis were to characterize the
magnitude and directionality of the regional WSS in a BAV aorta, and to design a
bioreactor capable of replicating these characteristics in vitro. This device will provide new
insights into the mechanobiology of BAV aortopathy and other flow-mediated
cardiovascular diseases.
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NOMENCLATURE
Symbols
h0

Height of the gap between the cone and plate

h( r )

Height between the cone and plate as moving toward the
bioreactor wall

k̂

Longitudinal unit vector

n̂

Normal unit vector of the target surface

r

Distance from the center of the cone to the center of tissue

R

Distance from the center of the cone to the bioreactor wall

Rc

Radius of the cone

Re

Rc 2  2 c
Reynolds number,
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T

Time period

Tangled face

Torque on the angled side of the cone

Tcone

Cone acceleration torque

Tcone side

Torque on the cone side

TTissue mount

Torque on the tissue mount



Cone angle



Angular deviation of the computed wall shear stress vector
on the tissue from the ideal flow (tangential) direction
v

θ̂

Circumferential unit vector



Dynamic viscosity



Kinematic viscosity



Working fluid density

τ

Instantaneous wall shear stress vector

circ

Circumferential component of wall shear stress

long

Longitudinal component of wall shear stress

total

Total wall shear stress



Angle between the longitudinal unit vector and the
instantaneous wall shear stress vector

c

Cone angular velocity

tissue

Tissue angular velocity

Abbreviations
AA

Ascending aorta

AV

Aortic valve

BAV

Bicuspid aortic valve

CAD

Computer aided design

CFD

Computational fluid dynamics

CMR

Cardiac magnetic resonance

COSI

Circumferential oscillatory index

ECM

Extracellular matrix
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FSI

Fluid-structure interaction

LOSI

Longitudinal oscillatory index

LR

Left-right coronary leaflet fusion

NL

Non-left coronary leaflet fusion

NRMSD

Normalized root-mean-squared deviation

MMPs

Matrix metalloproteinases

OSI

Oscillatory shear index

PC-MRI

Phase-contrast magnetic resonance imaging

PIV

Particle image velocimetry

RN

Right-non coronary leaflet fusion

RMST

Root mean squared total

TAV

Tricuspid aortic valve

TGF- 

Transforming growth factor-beta

TIMPs

Tissue inhibitor of metalloproteinases

transWSS

Transverse wall shear stress

TSM

Temporal shear magnitude

VSMC

Vascular smooth muscle cell

WSS

Wall shear stress
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CHAPTER 1:
INTRODUCTION

1.1

The Aorta
The aorta, the largest artery in the body, originates from the left ventricle of the

heart. Its main function is to transport oxygenated blood to the body. Oxygenated blood
comes from the pulmonary vein, enters the heart via the left atrium and then fills the left
ventricle prior to ejection. When the heart contracts, the blood is ejected through the
aortic valve to the aorta and the systemic circulation. The aorta can be divided into four
sections: the ascending aorta, the aortic arch, the thoracic aorta and the abdominal aorta
(Figure 1 [1]). While factors such as gender, age and body size affect the size of
ascending aorta, the average diameter of a normal human ascending aorta is 33 mm (31.4
mm in females, 37.4 mm in males [2]
The aortic wall is composed of three layers (Figure 2). Each layer serves different
functions and has different characteristics. The inner layer is the tunica intima and is the
interface between blood flow and the aortic wall. It continuously experiences the viscous
fluid shear stress exerted by the blood flow. It consists of a thin layer made up of
endothelial cells, subendothelial connective tissue and an internal elastic lamina. The
middle layer is the tunica media, which is responsible for the contractile ability of the
artery. It consists of multiple layers of smooth muscle cells embedded in their
1

extracellular matrix (ECM). Finally, the outer layer is the tunica adventitia, which
consists of connective tissue and nerves.

Figure 1. Different sections of the aorta: 1.) ascending aorta; 2.) aortic arch; 3.) thoracic
aorta; 4.) abdominal aorta

Figure 2. Cross-sectional view of the aortic wall. The aortic wall consists of
three layers: 1.) tunica intima; 2.) tunica media; 3.) tunica adventitia
2

1.2

The Normal Aortic Valve
The human heart contains four valves for achieving unidirectional blood flow.

The aortic valve (AV) is located between the left ventricle and the aorta (Figure 3). The
main function of the AV is to achieve unidirectional blood flow from the left ventricle to
the aorta during systole and to prevent backflow during diastole (Figure 4). The AV is
also known as aortic semilunar valve or tricuspid aortic valve (TAV) since the normal
AV consists of three pocket-like semilunar cusps. The cusps, also known as leaflets, are
referred to as the left-coronary, the right-coronary and the non-coronary leaflets,
according to their respective position relative to the coronary arteries (Figure 5).

aorta

left coronary ostia

right coronary ostia

left atrium

aortic valve
left ventricle
right atrium
interventricular septum

right ventricle
Figure 3. Heart anatomy

3

Figure 4. Heart valve function: the aortic valve closes during diastole and opens
during systole

left-coronary
leaflet

right-coronary
leaflet

left coronary ostia

right coronary ostia
non-coronary
leaflet

Figure 5. Short-axis view of the tricuspid aortic valve (TAV)

1.3

The Bicuspid Aortic Valve
The bicuspid aortic valve (BAV) is one of the most common congenital heart

defect in which two aortic valve leaflets remain fused during embryonic development.
This defect exists in 1-2% of the general population [3], [4]. Depending on the number of
fusion sites (raphes) present between the leaflets, BAVs are categorized into three types.
Type-0, type-I and type-II BAVs characterize BAVs with no raphe, one raphe and two
4

raphes, respectively (Figure 6-A). The type-I BAV is the most common (88% of the BAV
patients) [5] and can be further categorized into three morphotypes based on the position
of the leaflet fusion: left- and right-coronary leaflet fusion (LR-BAV), right- and noncoronary leaflet fusion (RN-BAV), and non- and left-coronary leaflet fusion (NL-BAV).
The LR-BAV is the most prevalent morphotype and accounts for 71% of type-I BAVs,
while the RN- and NL-BAV occur in 15% and 3% of type-I BAV cases, respectively
(Figure 6-B) [6]–[14].

L

type-II

type-I

type-0

A

R

N
7%

L

R

N raphe
88%

L

R

N
5%

raphe

B
LR (71%) RN (15%)

NL (3%)

Figure 6. BAVs exist in three types: A.) type-0 (no raphe), type-I (one raphe) and
type-II (two raphes); Type-I BAVs are further categorized into three morphotypes: B.)
LR-BAV, RN-BAV and NL-BAV

1.4

BAV Aortopathy
Previous research suggests that BAV is associated with secondary aortopathy,

such as aortic dilation [15], aortic aneurysm [16] and aortic dissection [17]. Aortic
dilation, the precursor of aortic aneurysm, results from vascular smooth muscle cell
(VSMC) apoptosis, elastic fiber degeneration and abnormal ECM remodeling [18].

5

1.4.1

Ascending Aortic Dilation
Aortic dilation is an abnormal enlargement of the aorta. Although both TAV and

BAV patients can develop ascending aortic dilation, BAV patients are at higher risk of
developing the disease [17], [19], [20] and the dilation patterns are quite different. When
aortic dilation develops in the AA of TAV patients, it is usually symmetric. In contrast,
asymmetric dilation patterns are usually observed in BAV AAs (Figure 7)[21]. The
incidence of aortic dilation in TAV patients with hypertension and BAV patients is 12%
and 35-68%, respectively [17], [19], [20]. Furthermore, BAV patients experience more
rapid dilation progression rate (0.2-1.9 mm/yr) than TAV patients (0.07-0.2 mm/yr) [22].

Figure 7. Aortic dilation patterns in A.) TAV; and B.) BAV aortas

AA dilation has been further categorized into three phenotypes based on the
location of the dilation on the AA: aortic root (type-1), tubular portion of the AA (type2), and the entire AA and the transverse aortic arch (type-3) [23]. Previous studies aimed
at investigating the relationship between BAV morphotypes and dilation phenotypes
through echocardiography and cardiac magnetic resonance (CMR) have indicated that
LR-BAV patients are prone to develop type-1 dilation (18 out of 92 LR-BAV patients)
and that type-1 dilation is exclusively observed in LR-BAV patients. In contrast, RN6

BAV patients are more likely to develop type-2 and type-3 dilation (24 out of 41 RNBAV patients) (Figure 8) [24], [25].

Figure 8. BAV morphotypes and their corresponding aortic dilation phenotype.
The circled numbers indicate the number of cases shift from one phenotype to
the other found in follow-up examination.

1.4.2

Aortic Dilation Pathobiology

VSMCs Apoptosis and Deficiency of Fibrillin-1
Previous biochemical studies have quantified the rate of VSMC apoptosis and the
levels of fibrillin-1, collagen and elastin in the aortic media of both TAV and BAV
patients. BAVs have been associated with a higher rate of VSMCs apoptosis than TAVs,
7

especially in the convexity of the aorta [26]. Furthermore, the levels of type-I/III collagen
measured in the convexity of BAV aortas where the dilation is prone to occur are lower
than in TAV aortas. Greater elastic fragmentation and less VSMCs have been observed in
the convexity as compared with the concavity of BAV aortas [27].
VSMCs are the major components of the tunica media and play an important role
in maintaining the structural integrity of the aorta. The two primary functions of the
VSMCs are 1.) to regulate the contraction of the vessel when mechanical stimuli are
sensed, and 2.) to synthesize ECM, which includes collagen, elastin, laminin,
proteoglycan, fibrillin, fibronectin and tenascin [28], [29].
Fibrillin-1, a glycoprotein, is the main component responsible for the structural
integrity of the aortic wall. Fibrillin-1 is required to bind VSMCs to the elastin/collagen
matrix. VSMC apoptosis occurs when the media is deficient in fibrillin-1, which causes
VSMCs to dissociate from the elastin/collagen matrix, resulting ultimately in a loss of
vessel structural integrity [4], [30].

Elastic Fiber Degeneration and ECM Remodeling
Matrix metalloproteinases (MMPs) are a type of enzymes that digest matrix
proteins and are synthesized by the cellular components of the vessel wall and
inflammatory cells. Previous studies have suggested that BAV aortic dilation may be
related to the high activity of MMPs, especially MMP-9. The release of MMP-9 can be
activated either when the levels of tissue inhibitor of metalloproteinases (TIMPs) are
decreased [31], [32] or when the transforming growth factor-beta (TGF-β) cascade is
triggered [33]. On the other hand, MMP-9 are two of the downstream targets of the TGF8

β pathway. Once the TGF-β cascade is triggered, MMP-9 activity is increased, leading in
turn to degradation of type IV collagen, elastin and fibrillar collagens, and causing ECM
remodeling, which eventually leads to aortic dilation [4], [34].

1.5

Aortic Dilation Diagnosis and Treatment
The average diameter of a normal human AA is 33 mm. AA aneurysm is usually

diagnosed either when the diameter of the dilated aorta is equal to or greater than 1.5
times the normal average diameter, or when the diameter exceeds 5 cm [35].
Depending on the severity of the aneurysm, surgery might be recommended. There are
two methods to treat ascending aorta aneurysm. The first method is reduction aortoplasty,
in which the dilated aorta is cut open, a section of the aortic wall is trimmed off and the
aorta is closed by suturing [36] (Figure 9 [6]–[14]). The second method is the Dacron
graft method and consists of replacing the dilated site of the aorta with a tube-shaped
Dacron graft made of synthetic material (Figure 10).

Figure 9. Reduction aortoplasty. A.) The enlarged, excessive aortic tissue in oval shape
is excised from the convexity of the AA, and B.) the opening is sutured to close.

9

Figure 10. Dacron Graft. A synthetic polyester tube which is used
for replacing and repairing blood vessels.

1.6

BAV Hemodynamics
Multiple studies have investigated the flow field in BAV AAs and its potential

role in aortopathy through in vivo [13], [37]–[41], in vitro [8], [42], and computational
[43], [44] techniques.

1.6.1

In Vivo Studies
Barker et al. performed clinical measurements using phase-contrast magnetic

resonance imaging (PC-MRI) to compare the regional WSS in TAV and BAV aortas
[13], [37]. The studies revealed that BAVs are associated with increased circumferential
WSS, and that LR-BAVs result in flow impingement on the right-anterior AA.
Retrograde, asymmetric flow patterns were also observed in BAV aortas.
Other studies conducted by Hope and colleagues aimed at investigating the flow
patterns and WSS abnormalities in BAV AAs via 4D PC-MRI [40], [41]. The studies
10

reported that BAVs cause eccentric, helical flow patterns at peak systole in the AA, with
asymmetrically elevated WSS. The results also evidenced that, although type-I BAVs
cause helical flow in the AA, the flow patterns and the location of flow impingement on
the AA wall are strongly dependent on the BAV morphotype. The LR-BAV generates
right-handed helical flow in the AA and causes the flow to impinge on the right-anterior
portion of the AA. In contrast, the RN-BAV generates left-handed helical flow and
results in flow impingement at the left-posterior portion of the AA. Similar results were
found in studies performed by Bissell et al. [39] and Mahadevia et al [38].
Bissel et al. attempted to identify the relationship between flow abnormalities and
aortic dilation via CMR analysis over a large sample size (95 BAV patients and 47
healthy volunteers). The results demonstrated that BAVs are linked to abnormal, higher
right-handed helical flow, higher systolic WSS and larger AAs as compared to the normal
TAV. It was also demonstrated that the abnormal flow in BAV patients occurs before the
development of aortic dilation, suggesting that the abnormal flow might induce
aortopathy [11].
Using 4D MRI, Mahadevia et al. demonstrated that BAVs cause eccentric outflow
jet patterns in the AA, which result in increased regional WSS. The locations of jet
impingement were the right-anterior wall in LR-BAV patients and the right-posterior
wall in RN-BAV patients (Figure 11)[38].

11

Figure 11. Comparisons of the flow patterns in A.) healthy volunteer; B.) aorta size
control; C.) LR-BAV AA; D.) RN-BAV AA. The flow pattern in the healthy
volunteer follows streamline. In contrast, the flow patterns are helical, and the jet
impinged at the right-posterior aortic wall regions in the LR-BAV and RN-BAV,
respectively.

1.6.2

In Vitro Studies
Particle image velocimetry (PIV) has been used to characterize quantitively and

qualitatively the flow field in TAVs and BAVs. By performing this in vitro analysis,
Saikrishnan et al. attempted to measure and characterize the flow environment generated
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by TAVs and LR-BAVs. They first aimed at studying the impact of jet eccentricity by
varying the level of stenosis on the BAV [9]. Other factors, such as jet angle, jet velocity
and aortic dilation, which may also exist in BAV patients, were taken into account in a
follow-up study [45]. The results demonstrated that BAVs generate increased systolic jet
velocity and flow impingement on the convexity of the AA wall, which results in a strong
vortex in the non-fused leaflet sinus. Moreover, increase in the level of turbulence and
WSS was also observed in BAVs relative to TAVs.
Other studies investigating the BAV flow characteristics through PIV experiments
were conducted by Seaman et. al. [8] and McNally et al. [42]. Seaman et. al. aimed at
quantifying the energy loss through the valve. The experiment was performed under
steady peak-systolic flow with normal and calcified TAVs and LR-BAVs. The results
revealed that BAVs are associated with higher energy loss relative to TAVs and result in
an elliptical orifice, which causes the jet to skew toward the non-coronary leaflet [8].
McNally and colleagues aimed at distinguishing the flow characteristics caused
by each type-I BAV morphotype (i.e., LR-BAV, RN-BAV and NL-BAV) under native
pulsatile flow. Both LR-BAVs and NL-BAVs resulted in increased peak-systolic orifice
jet velocity and WSS overloads on the AA convexity relative to TAVs [42].

1.6.3

Computational Studies
Computational fluid dynamics (CFD) and fluid-structure interaction (FSI)

modeling have been widely used for the hemodynamics characterization of blood vessels
at higher spatial and temporal resolutions than conventional imaging techniques such as
Doppler echocardiophy and PC-MRI [46]–[48].
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Previous in vivo study has revealed that the degree of jet skewness is proportional
to the AA diameter and the severity of aortic dilation [49]. Faggiano et al. aimed at
linking these findings to BAV flow characteristics during systole through computational
analysis [14]. CFD aorta models were constructed based on PC-MRI images of TAV and
BAV patients with varying valve orifice area and degree of aortic dilation. The results
demonstrated that the narrower orifice is, the more skewed the orifice jet would be.
Asymmetric jet was only observed in BAV cases, and all of them were reported with high
flow helicity and high systolic WSS magnitude in the AA.
Instead of studying flow characteristics in BAV aortas with pre-existing dilation,
Cao and colleagues designed TAV and type-I BAV aorta FSI models to quantify the
influence of the valve structure on the downstream hemodynamic environment in a
normal non-dilated AA. The results demonstrated that type-I BAV morphotypes cause
WSS overload on the AA convexity at peak systole, and WSS unidirectionality was
higher in the convexity of the proximal AA in all BAVs. The fact that BAVs cause
asymmetric helical flow and systolic WSS overload on the convexity of the AA was
confirmed [43].
Kimura et al. performed a patient-specific CFD analysis aimed at analyzing the
flow patterns and WSS distributions in TAV/BAV aortas [38]. The study revealed that
although the flow patterns in BAV patients differed greatly, abnormal helical flow was
present in the AA and transverse arch of all BAV patients. Furthermore, right-handed
helical flow was present in 91% of BAV aortas. Elevated WSS on the convexity of BAV
AAs and asymmetric flow in the BAV AAs were also detected. Notably, 3 out of the 4
LR-BAV patients and 1 out of the 2 RN-BAV patients exhibited flow impingement and
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elevated WSS on the right anterior wall and right posterior wall, respectively [44]. This
confirmed the flow characteristics reported by Mahadevia et al [18].

1.7

Etiologies of BAV Aortopathy

1.7.1

Genetic and Hemodynamic Etiologies
Two etiologies have been proposed to explain the link between BAV and

aortopathy. One suggests that BAV secondary aortopathy is genetic, while the other
suggests that it can also be due to abnormalities in the hemodynamic environment. The
abnormal blood flow and WSS generated by BAVs could trigger critical biological
processes (e.g., ECM remodeling, VSMC apoptosis, fibrillin-1 depletion [18], [21], [27])
leading ultimately to aortic dilation (Figure 12 [50]). Other studies have suggested the
existence of correlations between those hemodynamic abnormalities, the asymmetric
patterns of the aortic dilation on the convexity of the ascending aortic wall, and aortic
medial degradation [51].

Figure 12. Hemodynamic theory of BAV AA dilation
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1.7.2

Supporting Evidence of the BAV Hemodynamic Theory
As mentioned earlier, aortic dilation is a result of a series of biochemical

processes involving VSMC apoptosis, elastic fiber degeneration and abnormal ECM
remodeling [52]. These biological events are regulated by the expression and activity of
certain proteins and enzymes (i.e., fibrillin-1, TGF-β, MMP-2, MMP-9, TIMPs, etc.).
Biological analyses have been performed to investigate the levels/activities of these
components in TAV and BAV aortas. Fedak et al. and Boyum et al. analyzed TAV and
BAV aortic tissue samples using immunohistochemistry, fluorescence microscopy and
gelatinase zymography. The results revealed that BAV aortas exhibit decreased levels of
fibrillin-1 expression and increased MMP-2/9 activity relative to TAV aortas [53], [27].
To determine the role played by those proteins and enzymes in aortic dilation,
Cotrufo et al. [54] and Della Corte et al. [13], [37]–[41] performed comparative
biological analyses on the convexity and concavity of TAV and BAV aortas. Decreased
levels of type-I and type-III collagens and increased level of type-IV collagen were
observed in dilated BAV aortas relative to TAV aortas. Those changes were more
significant in the convexity of BAV aortas than in the concavity. Also, increased VSMC
apoptosis was detected in the convexity of BAV aortas. These studies concluded that
BAV aortas exhibit asymmetric ECM expression and increased VSMC apoptosis in the
AA convexity, which correlate with the asymmetric flow patterns evidenced by in vivo
[8], [42], in vitro [43], [44], and computational studies [21].
To demonstrate that abnormal WSS exerted on the convexity of the AA triggers
biological events and leads to aortic dilation, ex vivo biological experiments have been
conducted to investigate the acute biological response of porcine aortic tissue subjected to
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TAV and BAV WSS. These studies revealed increased MMP-2 and 9 levels following
tissue conditioning to WSS from the convexity of the BAV AA [55]. In contrast, there
was no significant difference in MMP-2 level when subjecting porcine aortic tissue to the
WSS from the TAV/BAV AA concavity [56].
Collectively, these studies provide preliminary supporting evidence for the role
played by hemodynamics in BAV aortic dilation.
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CHAPTER 2:
SPECIFIC AIMS

The BAV is a congenital valvular defect resulting from the fusion between two
leaflets [43]. While in vivo, in vitro and computational studies have evidenced that BAV
can cause helical flow patterns and abnormal WSS in the AA [57], previous flow
characterizations have focused on the quantification of the total or longitudinal WSS in
terms of magnitude and pulsatility [57]–[59]. The demonstrated increased helicity of
BAV flow is expected to generate a significant circumferential WSS component, whose
characteristics to date remain largely unknown. In addition, aortic cells respond to
hemodynamic stress abnormalities by activating critical biological processes, which may
lead to aortopathy. The elucidation of the cause-and-effect relationships between BAV
flow and aorta biology requires a device capable of subjecting native aortic tissue to its
local hemodynamic stress environment.
Different fluid shear stress bioreactors, such as the parallel plate flow chamber,
microfluidic devices and the cone-and-plate bioreactor, have been designed and used to
expose tissue samples to desired fluid shear stress environment [58]. Although those
bioreactors are capable of subjecting tissue samples to desired WSS magnitude, their
ability to replicate the actual native hemodynamic environment faces some limitations.
The native hemodynamic environment often involves time-dependent pulsatile WSS
magnitude and directionality. The parallel flow chamber can only produce shear stress at
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a constant magnitude. In fact, the fluid volume required to fill the bioreactor is typically
large, creating challenges in generating a pulsatile WSS due to the high fluid inertia [59],
[60].
Microfluidic devices have also been used to expose cells to desired WSS
magnitude. Such devices usually consist of a pump and cell culture chambers filled with
fluid. Pumps are used to push the fluid into/out of the chamber. The flow generated in the
chamber is Poiseuille flow, which results in uniform shear stress distribution on the
bottom surface of the chamber. However, such devices are usually designed with small
dimensions (e.g., 24-100 µm in depth and 200 µm in width) since their purpose is to
subject a cell monolayer to fluid shear stress [61], [62], limiting their application to the
conditioning of tissue.
The cone-and-plate bioreactor consists of an inverted rotating cone and a
stationary plate in which tissue samples are mounted. Culture medium fills the gap
between the cone and plate. When the cone rotates, fluid flow and uniform shear stress
are generated on top of the plate and tissue. Such device is capable of generating
temporal variations in WSS magnitude. However, the WSS generated is along the
circumferential cone direction, which prevents the replication of a multidirectional WSS
[5]. Hence, a new bioreactor is required to replicate the changes in magnitude and
directionality of the local WSS on native aortic tissue.
Therefore, the objectives of this thesis were to quantify the multidirectional
characteristics of the WSS caused by BAVs in the AA and to design a device capable
of subjecting native aortic tissue to native BAV WSS magnitude and directionality.
The quantification of WSS multidirectionality is described in Specific Aim 1, the design
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of the bioreactor is described in Specific Aim 2 and the determination of the device
operating conditions is described in Specific Aim 3.

Specific Aim 1: To quantify the multidirectional characteristics of BAV aorta WSS
in regions prone to dilation
Local WSS waveforms were obtained from valve-aorta FSI models published by
our group [21], [63]. The local WSS was characterized over two circular regions (7 mm
in diameter) located in the proximal section of the AA convexity and concavity. The
instantaneous WSS vector was extracted and decomposed into its longitudinal and
circumferential components. WSS multidirectionality was then quantified in terms of
temporal shear magnitude (TSM) and oscillatory shear index (OSI) in both directions,
and transverse WSS (transWSS). TSM and OSI are two frequently used indices for
quantifying the time-averaged magnitude and the oscillation nature of shear stress.
TransWSS is a new index for evaluating the multidirectionality of the flow by calculating
the instantaneous WSS components perpendicular to the direction of the mean WSS.

Specific Aim 2: To design a cone-and-plate bioreactor replicating the temporal
changes in WSS magnitude and directionality of BAV aortic tissue
The design was adapted from the cone-and-plate viscometer principle to subject
aortic tissue to desired time-varying WSS magnitude and direction. The device was
designed to accommodate four circular tissue samples. WSS magnitude was adjusted by
rotating an inverted cone above the culture medium, resulting in a fluid flow of culture
medium above the tissue specimens, and a WSS directly proportional to the cone
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velocity. Temporal changes in WSS directionality on each sample were achieved by
rotating the mounts supporting the tissue specimens. Computer-aided design (CAD)
drawings for each part of the physical model were created.

Specific Aim 3: To determine the bioreactor operating conditions
This aim consisted of determining: 1.) the optimal dimensions of the bioreactor,
2.) appropriate operating conditions, and 3.) the torque requirements for servo motor
selection. For the first task, CFD simulations were performed to assess the impact of
tissue location and cone radius on the validity of the equation relating cone velocity and
WSS. The predicted WSS magnitude and directionality were compared to the target WSS
extracted from the convexity of the LR-BAV AA (Specific Aim 1) over a range of cone
radii and tissue positions, and optimal bioreactor dimensions were determined based on
the correlation coefficient between the target and predicted WSS. The second task
implemented an iterative optimization method to determine the bioreactor operating
conditions (cone angular velocity waveform, tissue angular velocity waveform) resulting
in the desired WSS environment. Lastly for task 3, torque requirements were calculated
for the cone and tissue rotations based on the optimized WSS waveform.
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CHAPTER 3:
SPECIFIC AIM 1

3.1

Rationale
BAVs cause helical flow patterns and elevated WSS in the AA. Previous studies

have typically focused on characterizing BAV WSS abnormalities in terms of magnitude
and pulsatility abnormalities in global or longitudinal WSS [57]–[59]. Since the
circumferential WSS is a significant component in helical flows, substantial
abnormalities in circumferential WSS are also expected in BAV AAs. The quantification
of this component was thus required to provide the full characterization of WSS
abnormalities in BAV AAs.

3.2

Methods

3.2.1

TAV/BAV Aorta Fluid-Structure Interaction (FSI) Models
The FSI models used in this thesis were published previously by our lab. The

models consisted of four aortic valve geometries (TAV, LR-BAV, RN-BAV and NLBAV) connected to an idealized aorta reconstructed from a series of computed
tomography images of a human aorta [64]. The aorta geometry included the AA and the
aortic arch along with the entrance regions of the brachiocephalic (BCA), left common
carotid (LCCA), and left subclavian (LSA) arteries. The four valves consisted of one
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TAV geometry with three identical leaflets, and the three type-I BAV geometries with the
raphe placed along the common free edge of the fused leaflets (Figure 13) [43], [65]. The
compliance of the valve leaflets and the aortic wall was modeled using a three-parameter
Mooney-Rivlin model and a linear elastic model, respectively, calibrated with respect to
published tensile test data on valvular and aortic tissue [43]. Blood was modeled as an
incompressible, homogeneous and Newtonian fluid (density: 1050 kg/m 3 ; dynamic
viscosity: 0.0035 Pa  s ). Fully coupled, two-way FSI simulations were performed in
ANSYS 18.0 Fluent, Mechanical ADPL and System Coupling (ANSYS Inc) using the
arbitrary Lagrangian-Eulerian (ALE) approach. The governing equations consisted of the
momentum and continuity equations for the fluid domain, the momentum equation for
the structural domain, and three coupling conditions enforcing continuity of
displacements, velocities and tractions at the fluid-structure interface. All models were
subjected to the same physiologic transvalvular pressure waveform (0/12 mmHg, 2:1
diastolic/systolic ratio). The simulations predicted a cardiac output of 4.5 L/min for the
TAV aorta, and 4.0 L/min for the BAV aorta models, respectively [66], [67], which fall
within the range reported by published clinical studies [57].
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Figure 13. Valve-aorta FSI models. A.) TAV; B.) LR-BAV; C.) RN-BAV;
D.) NL-BAV

3.2.2

Longitudinal and Circumferential WSS Extraction
The WSS characterization was conducted in two circular target regions (7-mm

diameter) located in the convexity and concavity of the proximal AA section (Figure 14A). The surface-averaged WSS was extracted at each time step over one cardiac cycle.
The vector was then decomposed into its instantaneous longitudinal and circumferential
components,  long and  circ , respectively, following the procedure outlined below.
The longitudinal direction was identified as the normal unit vector k̂ to the cross
section of the aorta intersecting the two target regions (Figure 14-B). For each
interrogation region, the unit vector in the circumferential direction θ̂ was obtained as
the cross product between the outward unit normal vector n̂ to the target region and the
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longitudinal unit vector:
θˆ = nˆ  kˆ

(1)

As a result of this calculation, the circumferential direction always pointed in the
clockwise direction along the aortic wall, regardless of the location of the interrogation
region. Lastly, the local longitudinal and circumferential WSS components were obtained
by calculating the dot product between the local WSS vector and the respective unit
vector in each direction:

 long = τ  kˆ

(2)

 circ = τ  θˆ

(3)

and

Figure 14. WSS extraction A.) at the convexity and concavity; B.) in longitudinal
and circumferential directions.

3.2.3

WSS Characterization
The temporal changes in magnitude and direction of the local WSS vector τ were

assessed qualitatively by plotting the trace of the tip of the vector on a polar plot. The
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average magnitude of the total, longitudinal and circumferential WSS over one cardiac
cycle was quantified in terms of its respective TSM defined as

TSM =

1 T
 i dt
T 0

(4)

where  i =  total , long , circ  and T is the cardiac period. The change in directionality of
the WSS vector and the oscillatory nature of each component were quantified in terms of
the OSI [68] defined as
T

 dt 

1
0 i
OSI = 1 − T

2
 i dt 

0



(5)

The multidirectional characteristics of the flow were also assessed in terms of the
transverse WSS (transWSS), which indicates the degree of deflection of the WSS vector
from its average direction over the cardiac cycle [69], and is defined as


1 T 
transWSS =  τ   nˆ 
T 0




τ dt 
0
 dt
T
τ dt 
0





T

(6)

The value of the transWSS ranges from 0 to the total TSM. If the WSS vector oscillates
along the direction of the mean WSS vector over the entire cardiac cycle, then the flow is
unidirectional and transWSS is close to 0. If a large portion of the instantaneous WSS
vectors deviates from the mean WSS vector and contributes more toward the direction
perpendicular to the mean vector, the flow is relatively multidirectional. The closer the
transWSS value to its total TSM, the more multidirectional the flow is.
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3.2.4

WSS Angular Variations
WSS overload has been reported at the convexity of the AA from previous

studies. To assess the directionality of the elevated WSS, the temporal variations of WSS
orientation at the convexity over the entire cardiac cycle were evaluated by calculating
the angle (  ) between the longitudinal axis and the WSS vector at each time point. To
calculate  , the instantaneous WSS vector was first projected to the longitudinal axis by
performing inner product on these two vectors (Equation 7). Then, the angle at each time
step was obtained by taking the inverse cosine function (Equation 8).

cos  =

kˆ  τ
τ

(7)

 kˆ  τ 

 τ 

(8)

 = cos −1 

Angular variation was captured in full 360  range on the interrogation region over
the entire cardiac cycle, essentially quantifying the instantaneous WSS change in
direction at one specific location. This waveform was then equally segmented into 36
sectors along a unit circle, with instantaneous WSS sorted into the corresponding sectors
based on its angle orientation. The average WSS magnitude was then calculated for each
segment, and set as its dominant value.
To adequately quantify the change in direction associated with significant WSS
magnitudes, a criterion was established for all morphotypes. The maximum value was
selected amongst all geometries, and WSS quantity was normalized to it. WSS was
considered significant when the value exceeds 50% of the maximum WSS magnitude
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found among all the morphotypes. Polar histograms were created and used to identify the
angle distribution of the abnormal WSS magnitude (i.e., when the WSS magnitude is
50% larger than the maximum WSS among all morphotypes). The more quantities of
sectors exceed this 50% criterion are obtained means the larger range of angles the WSS
orientation covers.

3.3

Results

3.3.1

WSS Orientation and Angular Variations
The time history of the WSS vectors predicted in the convexity and concavity of

the proximal AA for the four valves are provided as videos in Appendix A and as polar
plots in Figure 15. While the results suggest that all valves subject the proximal aortic
wall to substantial changes in WSS directionality, TAV and BAV WSS differ in their
range of rotation and overall magnitude.
To examine the angle distribution without considering the WSS magnitude, the
TAV resulted in a wider range of WSS angles in the convexity than the BAVs (see Table
1). The TAV WSS vectors in the convexity and concavity were oriented at an average
angle of 286  and 55  , respectively, relative to the longitudinal direction over the cardiac
cycle. In the BAV aortas, the increased flow helicity tended to align the WSS vectors
along the circumferential direction (convexity WSS average angle: 255  ; concavity WSS
average angle: 185  ).
However, when taking the WSS magnitude into consideration (Figure 16), the
majority of the sectors in TAV polar plot fell within 50% of the maximum WSS
magnitude criterion among all morphotypes. Since TAV represented the normal
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physiologic case, sectors with WSS magnitude exceeded this 50% criterion is considered
as significant overload. All BAVs exhibited elevated WSS magnitude in the proximal AA
convexity, and those levels were experienced over a wide range of angles (Figure 17).
The range of the angles for each model is listed in Table 2.
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Figure 15. WSS magnitude vs. orientation in proximal convexity and concavity of A.)
TAV, B.) LR-BAV, C.) RN-BAV and D.) NL-BAV aorta models
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Figure 16. Angular distribution of normalized mean WSS magnitude at the proximal
convexity of the A.) TAV; B.) LR-BAV; C.) RN-BAV and D.) NL-BAV aortas. The
orange dash line represents the 50% threshold.
Table 1. Angle distribution in the convexity of the AA of all models

Range of

TAV

LR-BAV

RN-BAV

NL-BAV

180 

130 

150 

160 

Angles

Table 2. Width of WSS angle range for WSS magnitudes exceeding 50% of the
maximum WSS at the proximal convexity for all models
TAV

LR-BAV

RN-BAV

NL-BAV

10 

30 

50 

40 

Range of
Angles
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Figure 17. Summary of the number of sectors satisfying each criterion at the convexity
of AA for all valve-aorta models

3.3.2

WSS Magnitude Characteristics
WSS characteristics were quantified in the proximal AA convexity and concavity

of TAV and BAV AAs. Both the longitudinal and circumferential WSS components were
examined to assess the multidirectionality of the local WSS environment.

Total TSM
The raw data of the total TSM were summarized in Table 3. The total TSM was
higher on the proximal AA convexity downstream of a BAV than downstream of a TAV,
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regardless of the BAV morphotype (Figure 18). The models predicted overall WSS
magnitude overloads in all BAV AAs (LR-BAV; 134.4% increase, RN-BAV; 105.1%
increase, and NL-BAV; 95.6% increase with respect to the TAV). In contrast, total TSM
calculations in the proximal concavity revealed an overall decrease in WSS magnitude
(LR-BAV; 23.4% decrease, RN-BAV; 52.9% decrease, and NL-BAV; 32.4% decrease
with respect to the TAV).
An apparent trend observed was that the WSS overload on the convexity was
higher than that in the concavity for all BAV morphotypes. Although the LR-BAV
generated the highest values at both locations, the overload observed in the convexity was
substantially larger (37.8% increase) than in the concavity. The convexity of the RNBAV aorta experienced the most dramatic change in magnitude among all morphotypes
(96.0% increase vs. concavity).

Table 3. Total TSM (Pa) at convexity and concavity of all valve-aorta models
Convexity Concavity
TAV

1.44

3.20

LR-BAV

3.38

2.45

RN-BAV

2.96

1.51

NL-BAV

2.82

2.16

Longitudinal TSM
The raw data of the longitudinal TSM were summarized in Table 4. Similar to the
trend observed with the total TSM, the BAVs subjected the aortic wall to overloads in
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longitudinal WSS in the proximal AA convexity (LR-BAV; 53.3% increase, RN-BAV;
38.3% increase, and NL-BAV; 31.5% increase with respect to the TAV). Longitudinal
TSM predictions made in the concavity exhibited the same trend as the total TSM,
marked by an overall decrease in TSM (LR-BAV: 37.6% decrease, RN-BAV: 57.5%
decrease, and NL-BAV: 34.8% decrease with respect to the TAV). However, a different
pattern emerged in the concavity where BAVs generated higher longitudinal TSM than in
the convexity (LR-BAV; 11.4% increase, RN-BAV; 17.3% decrease, and NL-BAV;
27.3% increase with respect to the convexity).

Table 4. Longitudinal TSM (Pa) at convexity and concavity of all valve-aorta models
Convexity Concavity
TAV

0.96

2.67

LR-BAV

1.48

1.67

RN-BAV

1.33

1.14

NL-BAV

1.27

1.74

Circumferential TSM
The raw data of the circumferential TSM were summarized in Table 5. All BAV
morphotypes generated significant overloads in circumferential TSM on convexity of the
AA (LR-BAV: 242.4% increase, RN-BAV: 194.0% increase, and NL-BAV; 180.7%
increase with respect to the TAV). Furthermore, the circumferential TSM values are
larger than the longitudinal TSM shown in Figure 18, suggesting that the circumferential
WSS is the dominant component in the convexity of all BAV AAs.
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As compared to the proximal convexity, the concavity of BAV AAs exhibited an
overall decrease in circumferential TSM (LR-BAV: 47.9% decrease, RN-BAV: 70.3%
decrease, NL-BAV: 57.4% decrease vs. convexity). To compare the circumferential TSM
and the longitudinal TSM in the concavity of AA for all models, the longitudinal TSM is
higher than circumferential TSM for all models. That is, the flow is dominated by the
longitudinal component in the concavity for all valve-aorta models. The only exception
is with the LR-BAV morphotype for which both stress components are essentially similar
(longitudinal TSM: 1.67 Pa; circumferential TSM: 1.48 Pa), suggesting the strong
multidirectionality of the WSS environment generated by this morphotype.

Table 5. Circumferential TSM (Pa) at convexity and concavity of all valve-aorta models
Convexity Concavity
TAV

0.83

1.59

LR-BAV

2.85

1.49

RN-BAV

2.45

0.73

NL-BAV

2.34

0.99
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Figure 18. Total, longitudinal and circumferential TSM at the convexity and
concavity of the proximal AA
3.3.3

WSS Directionality Characteristics
The WSS directionality was characterized in terms of OSI and transWSS. was

quantified in the longitudinal and circumferential directions, in both the proximal AA
convexity and concavity for all valves. The OSI in the longitudinal and circumferential
directions were abbreviated as LOSI and COSI, respectively. The results are summarized
in Figure 19.
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Longitudinal OSI
In the proximal AA, all models generated WSS oscillation in the longitudinal
direction (Table 6). This is likely due to the successive forward and backward flows
generated during systole and diastole, respectively. Furthermore, the largest LOSI was
observed in the TAV AA. To be more specific, the LR-BAV, RN-BAV and NL-BAV
resulted in a 0.10-point, 0.17-point and 0.10-point decrease in LOSI in the convexity,
respectively, relative to the TAV. Among all BAV morphotypes, the RN-BAV predicted
the highest LOSI in the concavity.
The comparison of the OSI predictions in the convexity and concavity of BAV
AAs reveals that both the LR- and NL-BAV subjected the convexity to higher LOSI than
the concavity (LR-BAV: 0.04-point increase; NL-BAV: 0.06-point increase vs.
concavity). This trend was opposite with the RN-BAV, which subjected the wall
convexity to lower LOSI than the concavity (0.12-point decrease).

Circumferential OSI
COSI values extracted in the AA convexity of all models were close/equal to zero
(Table 7), suggesting the absence of back-and-forth oscillation of the circumferential
WSS component. In contrast, while all BAVs generated oscillatory WSS in both
longitudinal and circumferential directions in the proximal AA concavity (LOSI > 0.22,
COSI > 0.32), the TAV only generated oscillations in longitudinal WSS (LOSI = 0.30,
COSI = 0.02).
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Table 6. Longitudinal OSI at convexity and concavity of all valve-aorta models
Convexity Concavity
TAV

0.38

0.30

LR-BAV

0.28

0.24

RN-BAV

0.21

0.33

NL-BAV

0.28

0.22

Table 7. Circumferential OSI at convexity and concavity of all valve-aorta models
Convexity Concavity
TAV

0.02

0.02

LR-BAV

0.00

0.40

RN-BAV

0.00

0.40

NL-BAV

0.00

0.32

Figure 19. Longitudinal and circumferential OSI at the convexity and concavity of the
proximal AA
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Transverse WSS
The raw data of the transWSS and its ratio to the total TSM in the proximal AA for all
models are reported in Table 8. The higher the ratio, the greater the flow multidirectionality. In

the convexity of the proximal AA, all BAVs generated relatively low WSS directionality
(transWSS/total TSM ratio < 37.6%) relative to the TAV (transWSS/total TSM ratio =
61.1%). In contrast, all models resulted in relatively high WSS directionality in the
concavity (transWSS/total TSM ratio > 70.9%).

Table 8. transWSS and transWSS/total TSM ratio in the convexity and concavity of all
valve-aorta models.
Convexity

Concavity

transWSS (Pa)

Ratio

transWSS (Pa)

Ratio

TAV

0.88

61.1%

2.27

70.9%

LR-BAV

1.27

37.6%

1.76

71.8%

RN-BAV

0.84

28.4%

1.18

78.1%

NL-BAV

0.93

33.0%

1.84

85.2%
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Figure 20. Ratio of transWSS and total TSM in the convexity and concavity of the
proximal AA for all models.

3.4

Summary
WSS overloads were observed in the proximal convexity of all BAV AAs, with

the LR-BAV generating the most substantial increase. While both longitudinal and
circumferential TSM were increased in BAV AAs, the circumferential WSS component
dominates over the longitudinal component.
The multidirectionality of the WSS in the convexity was analyzed through
characterization of the angular distribution of the sectors. All BAV AAs exhibited wider
WSS angular ranges and larger WSS levels relative to the TAV AA. Asymmetric WSS
directionality patterns were observed in which high transWSS was observed in the
convexity of the TAV AA and the concavity of all models, while relatively lower
transWSS was obtained in the convexity of all BAV AAs.
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CHAPTER 4:
SPECIFIC AIM 2

4.1

Rationale
Previous in vivo studies [13], [21], [38], [40], [41], [70], [71] have suggested that

the WSS overload caused by BAVs on the aortic wall may contribute to aortic dilation.
However, those studies only focused on the longitudinal WSS component, discarding the
multidirectional nature of BAV WSS and the potential role played by the circumferential
WSS component. As a result, bioreactors used in BAV aortopathy studies have consisted
of cone-and-plate systems subjecting aortic tissue to longitudinal BAV AA WSS. The
elucidation of the cause-and-effect relationship between BAV WSS and tissue biology
requires a device capable of replicating the time-varying magnitude and directionality of
the native WSS. To address this need, this aim describes the design of a novel device
capable of subjecting multiple tissue samples to time-varying WSS magnitude and
directionality, while maintaining tissue viability through nutrient and oxygen supply.
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4.2

Design Principle

4.2.1

Components Description
The design principle is based on a cone-and-plate bioreactor, which consists of an

inverted cone rotating above a stationary plate and driving a fluid flow in the gap
between the cone and the plate, where c is the cone angular velocity, Rc is the radius of
the cone,  is the fluid density,  is the dynamic viscosity,  is the cone angle, h0 is the
gap and h(r ) is the height between the cone and plate at the radial location r (Figure
21). As a result, a WSS is exerted on the plate.
Rc

ωc

z
α

fluid (𝜌, 𝜇)

h0

h(r)

r
Figure 21. Cone-and-plate bioreactor.

The Reynolds number for this cone-and-plate bioreactor is defined as,
Re =

Rc 2  2 c
12

(9)

where  is the kinematic viscosity [72].
Previous study has demonstrated that to produce an axisymmetric, laminar and
tangential flow, the Reynolds number has to be less than 1. If the Reynolds number falls
within a range from 1 to 4, secondary flow effects will be present, and as the value goes
beyond 4, the flow is fully turbulent [73].
42

4.2.2

Fluid Mechanics of the Cone-and-Plate Device
The relation between the cone angular velocity and the resultant WSS on the plate

can be determined by solving the Navier-Stokes and continuity equations. The NavierStokes and continuity equations were simplified based on five assumptions: i.) steady
flow (


= 0 ), ii.) purely circumferential flow ( vr = 0 and vz = 0 ), iii.) rotational
t

symmetric flow (

v
= 0 ), iv.) no body force ( g = 0 ) and v.) no imposed pressure


gradient in the tangential direction (

p
= 0 ) . In addition, under the assumption of a very


small cone angle  , the height of the fluid gap can be formulated as
h ( r ) = h0 + r tan  = h0 + r

(10)

Based on the assumptions, the Navier-Stokes equations reduce to:
N-S/r:

 v 2  p
  =
 r  r

(11)

N-S/  :

2
  1 
  v 
0= 
rv
+
(  )
2 
 z 
 r  r r

(12)

0=

N-S/ z :

−p
z

(13)

By introducing the following scaled variables,
r* =

v
r
z
; z* = ; v * =  ,
R
h0
R

the N-S/  equation can then be rewritten:
  1 
R 2  2 v *  
0 =  *  * * ( r *v * ) + 2

h0 z *2  
 r  r r
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(14)

Under the assumption of a very small gap between the cone apex and the plate (i.e.,
2

R
 2 v
h0  R ),    1 and
is the dominant term of the equation. The scaled Navierz *2
 h0 

Stokes equation simplifies to
 2 v
=0
z 2

(15)

This equation can be integrated twice to obtain the tangential velocity equation:
v = C1 z + C2

(16)

From the no-slip conditions at the plate, v ( z = 0) = 0 , and at cone, v ( z = h(r )) = r c ,
the constants of integration are determined as C2 = 0 and C1 =

rcone
, respectively.
h0 + r

Equation 16 then can be re-written as
v =

rc
z
h0 + r

The shear stress along the  -direction is defined as  z = 

(17)

v
, where  is the dynamic
z

viscosity of the fluid. Using Equation 17, it results that

 z = 

rc
h0 + r

(18)

In the limit of a small gap between the cone apex and the plate (i.e., h0 → 0 ),
theoretically, the WSS magnitude generated by the cone rotation is directly proportional
to the prescribed cone angular velocity, and the relation between   z and  c reduces to

 z =



 c

(19)

This equation demonstrates the existence of a uniform tangential WSS on the
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surface of the plate when certain conditions are met (i.e., small cone angle, cone apex
extremely close to the bottom plate, large cone radius relative to the height of the fluid
gap, and low Reynolds number to ensure circumferential flow). However, practically, the
distance between the cone apex and the bottom plate is finite and the WSS becomes
spatially-dependent on the bottom plate (see Equation 18). Therefore, the design of the
bioreactor needs to account for the radial dependence of the WSS [49].

4.3

Design Solution

4.3.1

Overview
As demonstrated in Specific Aim 1, the WSS characteristics in TAV and BAV

AAs not only differ in magnitude but also in directionality (i.e., increased WSS with
wider angular variations were observed in BAV AAs). Besides, both WSS magnitude and
directionality change as a function of time. Given that the cone rotation can only produce
a tangential WSS on the plate surface, a change in WSS directionality can only be

servo
drive

laptop
computer

servo drive

servo motor

perfusion
system

reservoir

pump
plate

tissue
sample
culture
medium

cone
servo
motor

tissue mount
driving belt

Figure 22. Culture system schematic
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achieved by altering the orientation of the tissue specimens mounted on the plate. The
original cone-and-plate bioreactor design was therefore adapted to implement rotating
tissue mounts driven by a programmable servo motor. Four tissue mounts were equiangularly placed on the bottom plate to minimize the possible flow disturbances caused
by one sample on the sample immediately downstream, while providing a sufficient
number of samples to generate statistically meaningful biological results. Perfusion
pumps were used to circulate culture medium through the system (Figure 22).
The entire system is composed of four major modules and a driving system. The
modules include the cone assembly, the tissue mount assembly, the bioreactor case
assembly and the perfusion system (Figure 23). The driving system include servo/
motors. The function and design of each part is described in the following sections and
the definition of each part is attached in Appendix B.

Figure 23. Assembly components. A.) Cone assembly; B.) Tissue mount
assembly; C.) Bioreactor case assembly
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4.3.2

Cone Assembly
The cone assembly is responsible for achieving the desired time-dependent WSS

magnitude. To achieve any desired WSS magnitude, Equation 12 is used, and the
corresponding angular velocity will then be prescribed for the cone motion. In theory, the
computed WSS output from the calculated cone angular velocity should match the target
WSS.
The cone assembly consists of an inverted cone, a top driving shaft, a top flange
and a bottom plate container (Figure 24). The dimensions of the cone and the plate were
determined in the Specific Aim 3 through CFD analysis. The cone has an 80 mm
diameter and a 179.5° cone angle, and is made of Delrin. The material of the cone was
chosen based on the previous cone-and-plate bioreactor design [74]. In order to generate
a WSS distribution on the plate as uniformly as possible, it is required to ensure the cone
angle is 0.5° from the bottom plate when machining the part.

Figure 24. Cone assembly in cross-sectional view. Showing A.) components and their
corresponding locations; B.) cone in closer view
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The top driving shaft is a rotatory step-down shaft made of aluminum (5.00 mm
diameter, 12.0 mm length; 4.76 mm step diameter, 5.00 mm step length). The step-down
end of the shaft is connected to the motor shaft through a helical coupling (61005K191,
McMaster-Carr, Aurora, OH), and the other end of the shaft is connected to the cone.
The top flange is placed above the cone. The top flange has a 98 mm outer
diameter, 93.5 mm inner diameter and 8.35 mm thickness, and is made of biocompatible
stainless steel. It is beneficial to use biocompatible stainless steel, because: 1.) it allows
direct contact of the culture medium without causing any chemical reaction; 2.) autoclave
can be performed to ensure the part is sterile and thus prevent contamination problems.
The plate and the side wall are integrated into one piece, and becomes a bottom
plate container. The bottom plate container is placed inferior to the cone with a vertical
distance of 200 µm from the cone apex to the plate. Raised surfaces were created on both
the top and bottom of the container in order to fit with the edges of the top flange and the
working fluid reservoir (introduced in section 4.2.4), respectively. The raised surface at
the top connects to the top flange, and it has a 93.5 mm outer diameter, a 82.0 mm inner
diameter and a 2.00 mm thickness. The side wall of the container has a 98.0 mm outer
diameter, a 93.5 mm inner diameter and a 5.88 mm height. The raised surface at the
bottom connects to the working fluid reservoir, and it has a 98.0 mm outer diameter and a
93.5 mm inner diameter and a 2.00 mm thickness. Four circular openings (9.00 mm
diameter) were created 20 mm away from the plate center, and every 90° along the
circumferential direction on the plate surface (82 mm diameter). These four circular
openings are where the tissue samples will be located. The entire bottom plate container
is also made of biocompatible stainless because of the same reasons described previously.
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4.3.3

Tissue Mount Assembly
The tissue mount assembly is responsible for achieving the desired WSS

directionality. The WSS generated by the cone rotation is always unidirectional. To
expose the tissue to WSS in different directions, the tissue mounts are rotated as desired,
which will then render relative orientation to the WSS.
The tissue mount assembly consists of four tissue mounts, four small driving shafts,
one large driving shaft, four small driving gears, one large driving gear and five ball
bearings. The tissue mount is a rotatable structure which was integrated from a circular
platform and a rotatory step-down shaft, and is made of biocompatible stainless steel.
The circular platform is 7 mm in diameter and has eight pinholes align along the
edge. The diameter of the platform was determined according to the previous design, in
which the tissue samples were 7 mm in diameter. The tissue samples extracted from the
aortic wall will be fixed on the circular platform by suturing the edge of the tissue
through the pinholes. The step-down shaft (4.76 mm diameter, 14.0 mm length; 3.18 mm
step diameter, 11.0 mm step length) is connected to the bottom shaft through helical
coupling (6208K425, McMaster-Carr, Aurora, OH). The vertical height of the tissue
mount was designed to be adjustable, in order to adapt the thickness of the tissue sample
(Figure 25).
The small driving shaft is an aluminum cylinder (3.18 mm diameter, 28.0 mm
length) with a small driving gear (57655K33, McMaster-Carr, Aurora, OH) attached to it.
They are then installed onto a ball bearing (60355K501, McMaster-Carr, Aurora, OH)
fixed at the bottom of the supporting cylinder (introduced in section 4.2.4).
The large driving shaft is a rotatory step-down shaft (6.35 mm diameter, 11 mm length;
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4.76 mm step diameter, 40 mm step length) with a large driving gear installed on the top.
It is attached to the supporting cylinder with a ball bearing (60355K501, McMaster-Carr,
Aurora, OH), and connected to the bottom motor shaft through a helical coupling
(61005K191, McMaster-Carr, Aurora, OH). The large driving gear received the rotatory
force received from the motor shaft and transports it to the small driving gears. The small
driving gears then trigger the rotation of the tissue mounts (Figure 26).
tissue
mount
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small
driving
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small
driving
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Figure 25. Tissue mount in A.) Overview; B.) Cross-sectional view; C.) Top view

Figure 26. Tissue mount assembly in cross-sectional view
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4.3.4

Bioreactor Case Assembly
A working fluid reservoir is placed inferior to the plate, and separates the gearings

underneath from the fluid stored inside the reservoir. The structure is similar to the
bottom plate container. The raised surface at the top connects to the bottom plate
container, and the raised surface at the bottom connects to the supporting cylinder. Seals
(13125K67, McMaster-Carr, Aurora, OH) are applied at the interface between the tissue
mounts and the holes on the bottom of the working fluid reservoir to prevent the leaking
of the fluid.
The working fluid reservoir combined with the top flange and the bottom plate
container to form a closed space, which will be filled with culture medium (Dulbecco’s
Modified Eagle’s Medium-high glucose, Sigma-Aldrich Co., St. Louis, MO; dynamic
viscosity: 0.00095 kg.m-1s-1).
A hollow-carved supporting cylinder is placed inferior to the working fluid
reservoir to support the cone and tissue assemblies. As mentioned in the previous section,
the small driving shafts and the corresponding ball bearings from the tissue mount
assembly are fixed at the bottom of the supporting cylinder. The supporting cylinder has
a 98.0 mm diameter, and 53.1 mm height, and is made of aluminum. The hollow-carved
feature was designed for easy access to the tissue mount assembly (Figure 27).
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Figure 27. Bioreactor case assembly in A.) overview; B.) cross-sectional view

4.3.5

Perfusion System

Perfusion Pumps
Two perfusion pumps are required to circulate the culture medium through the
culture system. One is responsible of transporting the culture medium from the external
reservoir into the bioreactor, and the other is responsible of returning the excessive fluid
back to the external reservoir for next round of circulation.
The total volume of the culture medium required to fill the bioreactor was
calculated. The main requirement of the flow rates is that the pumps should be able to
replenish the total volume of culture medium in the bioreactor every hour. Therefore,
pumps with flow rates close to or higher than 0.87 mL/ min was required. Based on the
minimum required flow rate, SP200 OEM Fixed-Flow Peristaltic Pump (APT
Instruments, Rochester, IL) with a flow rate at 0.92 mL/min was selected.
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External Culture Medium Reservoir
In order to supply the tissue samples in the bioreactor with fresh culture medium
for 24 hours, the required amount of the fresh culture medium is 1247 mL. An external
reservoir was designed in order to store the fresh culture medium before transported into
the bioreactor. The external reservoir is a rectangular box with a fluid capacity of 1311
mL (101.6 mm length, 101.6 mm width and 127.0 mm height). The fluid capacity was
designed to be 10% larger than the required fluid volume. Since the reservoir will directly
contact with the culture medium, it is made of biocompatible stainless steel.

4.3.6

Driving System
Two servo/ motors were required to prescribe cone and tissue mount rotations.

The motors are chosen from Parker-Hannifin Corporation, Cleveland, OH. Details about
the determination of the operating conditions and the justification for selecting the motors
are discussed in Specific Aim 3. Briefly, model number PM-FALR5AM8 was chosen for
controlling the rotations of the cone and the tissue mounts.
Since this system consists of two servo/ motors and it is required that they operate
at the exact same time steps, Parker Automation Controller (PAC) are added into the
system to ensure the motors receive the signals and rotate simultaneously. PAC is a
signal-integrated device. It combines the signals from two separate servos, and ensure the
motors received the signals without any time difference.
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4.4

Summary
A fluid shear stress bioreactor was designed based on the principle of the cone-

and-plate viscometer, and modification was made at the bottom plate in which the tissue
sample will be fixed on the free-rotated tissue mount. The desired WSS magnitude and
directionality were then achieved by the cone and tissue rotation. The CAD drawings for
each component in the culture system were generated, and model of the perfusion pumps
were selected based on the required flow rate.
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CHAPTER 5:
SPECIFIC AIM 3

5.1

Rationale
As mentioned in Specific Aim 2, a fluid shear stress bioreactor has been designed

based on the principle of cone-and-plate viscometer to subject tissue sample to its native
WSS environment. In this previous design, the cone is the only component that has
motion. In order to replicate the WSS directionality, rotating tissue mounts were adapted
into the current design, and thus changed the model operating environment. Therefore, it
is required to study if changing the dimensions of the bioreactor will better satisfy
Equation 18. The operating conditions for this new bioreactor also needed to be
determined, and the proper servo/ motors were selected based on the suggested operating
conditions.

5.2

Methods
The first objective of the CFD analysis was to determine the optimal dimensions

of the bioreactor. The flow disturbances caused by the wall and tissue rotation effects
were minimized with the optimal dimensions. The second objective was to determine the
appropriate operating conditions through an iterative waveform optimization process. The
third objective was to select the proper servo/ motors based on the operating conditions.
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5.2.1

Computational Fluid Dynamics (CFD) Models
Bioreactor CFD models were created and mesh dependency tests were performed.

These models were then used in Section 5.2.2 and 5.2.3 for determining the optimal
dimensions and the operating conditions, respectively, for the bioreactor.

Bioreactor Geometry
To study how changing the dimensions of the bioreactor will have influences on
the results, five bioreactors with different dimensions were considered, and the
corresponding fluid domains in three-dimensions (3D) were created in SolidWorks and
imported into ANSYS CFX. Owing to the symmetry, only a quarter of the bioreactor
(i.e., a 90° slice) was created and used for the CFD simulation. This was beneficial for
saving the computation time. Since there were no fluid-structure interactions involved
and the focus was on the resultant WSS on the tissue surface, only the fluid domain was
modeled in this CFD analysis. The fluid domain is the culture medium (Dulbecco’s
Modified Eagle’s Medium-high glucose, Sigma-Aldrich Co., St. Louis, MO). The density
and the dynamic viscosity are 1040 kg/m3 and 0.00095 kg.m-1s-1, respectively.
Two scenarios were considered when determining the dimensions. The first
scenario took only the radius of the bioreactor ( Rc ) (i.e., the distance from the cone apex
to the lateral wall of the bioreactor) into account, and tissue was kept at the original
location. In the second scenario, both the radius of the bioreactor and the tissue location (

r ) were manipulated. A total of five models were studied. Model 1 has a radius of 41
mm, and the distance from the plate center to the tissue center is 20 mm. Model 1 was
considered as the original model, since the dimensions have been validated previously as
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a good option for generating uniform WSS. Model 2 and 3 were defined as when both the
radius and the tissue location increased by 20 percent and 50 percent, respectively.
Finally, Model 4 and 5 were when only the radius was increased by 50 percent and 100
percent while maintaining the tissue at same location as in the original model. The other
parameters, such as the angle of the cone (  ), and the gap between the cone apex and the
plate ( h ), were kept as the same through all models. The schematic of the bioreactor is as
shown in Figure 28, and the summary of the dimensions of each model is as listed in
Table 9.

servo motor

tissue
sample

plate

ωc
cone
fluid

α

h

culture
medium

r
R

Figure 28. Bioreactor schematic (h = 200 µm and α = 0.5˚)
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Table 9. Model numbers with their corresponding descriptions and dimensions
Model No.

Description

R (mm)

r (mm)

1

Original

41

20

2

20%

49.2

24

3

50%

61.5

30

4

50%, original tissue location

61.5

20

5

100%, original tissue location

82

20

Boundary Conditions
The entire geometry was divided into seven sections, which include the bottom
plate, the lateral surface, the free surface, the cone surface, the tissue surface, and two
symmetry sections (Figure 29). The bottom plate was a stationary no-slip wall condition,
and it was where the tissue samples are placed. The lateral surface was the side wall of
the bioreactor; therefore, it was assigned a stationary no-slip wall condition as well. The
free surface is a 1-mm gap between the edge of the cone and the bioreactor wall, and a
condition of zero shear was imposed. Both the cone surface and the tissue surface were
assigned a no-slip rotating wall condition. However, when performing the mesh
dependency test, the tissue surface was not prescribed with any motion. In other words,
the tissue surface was just a no-slip stationary wall in the mesh dependency test. Finally,
the symmetry sections were assigned a rotational periodicity boundary condition for the
symmetric geometry.
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cone surface (no-slip rotating wall)
free surface (zero shear)

rotational periodicity
interface

lateral surface (noslip stationary wall)
tissue (no-slip
stationary/ rotating
wall)
bottom plate (no-slip stationary wall)
Figure 29. Boundary condition at each section

Mesh Dependency Test
Mesh dependency test was performed on each model. A constant WSS magnitude
at 5 Pa was considered as the target. Since the cone angular velocity required for
generating the target WSS depends on the radius of the tissue location, the corresponding
speed was calculated for each model by using Equation 18, and is listed in Table 10.
Since the geometry is thin and curved, the “Proximity and Curvature” was
selected for the size function, and the relevance center was set as “fine”. Inflation was
applied at the tissue surface. The mesh was composed of tetrahedral elements and made
finer in each round by increasing the number of cells across the gap from 3 to 8.
After the mesh was generated, a series of simulations were performed under
steady state. The tissue surface was kept stationary, while the cone surface is rotating at a
constant angular velocity corresponding to the value of target WSS. Once the simulation
was completed, the computation time, the total WSS and the torque on the tissue were
obtained in CFD-post, and recorded for each round. The percent differences then
calculated and compared between successive mesh refinement. The mesh size was
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determined based on the required computation time of the simulation and the accuracy of
the results. The most propriate mesh size was the one costed acceptable amount of
computation time while providing accurate and converged results (i.e., when the results
show less than 5% change as compared with the previous round).

Table 10. The calculated cone angular velocity for each model for mesh dependency test

5.2.2

Model No.

Description

Cone Angular Velocity (Rad/s)

1

Original

98.6

2

20%

89.8

3

50%

81.0

4

50%, original tissue location

98.6

5

100%, original tissue location

98.6

Determination of Bioreactor Dimensions
The addition of the rotating tissue changes the operating environment. Thus, it

was required to study whether changing the dimensions of the bioreactor will better
satisfied Equation 18. To perform the analysis, the CFD models created in Section 5.2.1,
and the target WSS waveforms obtained from the LR-BAV aorta FSI model in Specific
Aim 1 were used.
To determine the optimal dimensions of the bioreactor, the bioreactor CFD
models created in the previous section were switched from steady flow to transient flow.
The boundary conditions for most sections of the geometry were kept as the same as
described in the Section 5.2.1. Only slight changes were made on the cone surface and
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tissue surface, in which both sections were assigned a no-slip rotating wall condition.
Since the cone rotation is responsible for achieving target WSS magnitude,
Equation 18 was used in order to convert the target WSS to its corresponding cone
angular velocity function. This cone angular velocity function was then prescribed to the
cone surface in the CFD model.
Inner product was taken on the longitudinal vector ( k̂ ) and the WSS vector ( τ )
to obtain the angular variation as a function of time (Equation 7). After the angular
variation as a function of time was obtained by taking inverse cosine (Equation 8), the
tissue angular velocity function ( tissue ) was then calculated by taking the derivative of
the angular variation function (Equation 20). This function was then prescribed to the
tissue surface in the CFD model. The simulations were performed for two cardiac cycles
with a step size of 0.0025 s., and the data were extracted from the last cardiac cycle.

tissue ( t ) =

d
dt

(20)

Normalized Root-Mean-Squared Deviation Calculation
The WSS obtained from each model was then compared with the target WSS by
calculating the normalized root-mean-squared deviation (NRMSD) as shown in Equation
21. The smaller value of the NRMSD means the output WSS matches the target WSS
more as compared with the other models, and the model with smaller NRMSD was
selected.

NRMSD =

 (WSS

computed

− WSStarget )

2

MaxWSStarget − MinWSStarget
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(21)

5.2.2

Determination of the Operating Conditions
The determination was carried out on the model selected from the previous

section. The purpose of this determination was to show that the bioreactor can generate a
WSS output that matches the target WSS in terms of both magnitude and orientation.
As mention previously, the WSS magnitude generated on top of the tissue surface
is directly proportional to the cone angular velocity under ideal conditions. However, the
CFD analysis showed that the computed WSS on the tissue surface did not perfectly
match to the target WSS magnitude (Figure 30). The reasons for this discrepancy include
the fact that the bioreactor geometry was not ideal, and the flow disturbance caused by
the high rotating speed of the cone and the tissue rotation. In order to achieve the target
waveform, a waveform optimization method was proposed as described below.

Figure 30. Comparison between the target WSS and the computed WSS output
in magnitude. The computed WSS deviates from the target at the peak.
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Strategy Outline
Figure 31 is the summary flowchart showing how the operating conditions were
determined. Generally, any target WSS magnitude is converted to its corresponding
angular velocity through Equation 18 (block 1-3). This corresponding angular velocity is
applied to the cone surface in the CFD model, and simulation is performed (block 4). The
computed  ( t ) is then compared to the target, and the goal is to obtain a computed  ( t )
which has a R 2 value with the target at least higher than 0.95 and yields a WSS output
with % error lower than 5.0%. If the criteria are achieved, the WSS input is immediately
validated (block 5). However, if they are not , then a waveform optimization process is
required. WSS input is scaled, converted to its corresponding angular velocity, and
prescribed to the cone rotation (block 6). This process is repeated until the computed
 ( t ) passes the criteria. Once the optimized WSS magnitude waveform is determined,

the WSS angular variation on the tissue is then verified based on the optimized WSS
magnitude waveform. Same criteria are applied. Details on how the waveform
optimization process for the WSS magnitude was performed are discussed in the
following section.
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Figure 31. Operating condition strategy flowchart. Blue lines represent the general
process, red lines represent the waveform optimization process for WSS magnitude
and yellow lines represent WSS angular variation correcting process.
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Implementation to LR-BAV AA WSS Generation
In this determination of the operating conditions, the target WSS waveforms were
obtained from the proximal convexity AA of the LR-AV aorta FSI model in Specific Aim
1. The target WSS magnitude waveform was converted to the corresponding angular
velocity waveform by using Equation 18. Then, this calculated cone angular velocity was
prescribed to the cone surface in the CFD model.

Waveform Optimization/ Correcting Process
Three steps were required for optimizing the WSS magnitude waveform. First
step was to obtain the scaling factor by taking the ratio of the target and the initial WSS
magnitude output at every time point. This scaling factor was then applied back to the
initial WSS magnitude input to obtain a scaled input as the second step (Figure 32).
Finally, this scaled WSS magnitude input was converted to its corresponding cone
angular velocity by using Equation 18, and simulation was performed. These steps were

Figure 32. Comparison between the initial WSS magnitude input and the scaled
WSS magnitude input
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repeated, if necessary, until the % error and R 2 were less than 5.0% and greater than
0.95.
The verification of the WSS angular variation on the tissue was performed after
the optimized WSS magnitude input was determined. To calculate the WSS angular
deviation, the optimized WSS magnitude output was projected along the tangential axis
by performing inner product on the normalized WSS magnitude output and the
normalized tangential vector. The definitions of the tangential direction, angular
deviation and the WSS vector are as illustrated in Figure 33. Black arrow represents the
tangential direction, which is the ideal flow direction generated by the device. Red dash
line represents the computed instantaneous WSS vector, which deviates from the ideal
direction. The angular deviation,  , was then obtained by taking inverse cosine from the
inner product (Figure 34). By adding/ subtracting  from the target, the computed WSS
angular variation on the tissue was obtained (Figure 35).

Figure 33. Definition of the tangential direction, angular deviation and
computed WSS vector.
66

Figure 34. Error in WSS angle at each time point over the entire cardiac cycle.

Figure 35. Comparison between the target and computed WSS angular variations.
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Before correcting the WSS angular variation waveform, another simulation
without prescribing motion to the tissue was performed. The angular deviations observed
from both cases were then compared to identify whether it was a result of the tissue
rotation. The angular deviations and the computed WSS angular variations were obtained
by following the steps described above, and the results are shown in Figure 36 and
summarized Table 11.
The results demonstrated that whether tissue is rotating or not, the WSS angular
deviations were present, and there are no significant differences between two cases. In
other words, the WSS angular deviations was a result of cone rotation. Since that,
correction on the WSS angular variation waveform could be made by adjusting the tissue
rotation. Once the corrected WSS angular variation waveform was obtained, and the new
tissue angular velocity was calculated.

Figure 36. Comparison of WSS angular deviations between two cases: 1.) with tissue
rotation and 2.) without tissue rotation.
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Table 11. The calculated NRMSD and R 2 values in WSS angular deviations when
simulation performed 1.) with tissue rotation and 2.) without tissue rotation
Case Description

NRMSD

R2

With Tissue Rotation

18.6%

0.921

Without Tissue Rotation

18.5%

0.922

Normalized Root Mean Squared Deviation Calculation
After the simulation with the optimized WSS input was completed, the WSS was
extracted from the tissue surface. The resultant WSS was then compared with the target
WSS waveform in terms of the NRMSD (Equation 21) and R 2 value.

5.2.3

Torque Calculations for Motor Selections
After the operating condition was determined (i.e., the optimized WSS input

waveform), the torque was calculated based on the angular velocity function derived
from the optimized waveform. To calculate the torque, the bioreactor was first separated
into three sections: the cone side the angled face and the cone itself (Equation 22-24).

Tcone side =

Torque on the cone side:

Torque on the angled side:

Tangled face =

c
2 Rc H c

c log ( Rc )

(23)



Tcone = I 

Cone acceleration torque:

(22)

(24)

where  is the kinematic viscosity ( 0.00095 10−6 m2 s −1 ),  c is the angular velocity, Rc
is the radius of the cone, H c is the height of the cone, I is the total inertia and  is the
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cone acceleration. Th root mean square of the torque was calculated based on the
summation of the torques and the interval at each time step (Equation 25).

Root mean squared total:

RMST =

T

total

t

ttotal

(25)

Similar process was performed for calculating the torque for rotating the tissue
mounts. Since there are four tissue mounts rotating simultaneously, the torque was first
calculated based on one of them and multiplied by four at the end (Equation 26).
Torque on the tissue mounts:

5.3

Results

5.3.1

Mesh Dependency Test

Ttissue mount =

4tissue log( Rtissue )



(26)

The WSS and the torque extracted from the tissue were compared in each model
as the number of the cell cross the gap increases. A decreasing trend from four to eight
cells across the gap was observed in each model for both WSS and torque data (Figure 37
and Figure 38).
In Model 1, the percent difference in WSS on the tissue was 5.81% with four cells
across the gap (vs. three cells across the gap) and it immediately reduced to 3.06% in the
next mesh setup (i.e., five cells across the gap). On the other hand, the percent difference
in torque was 12.4 % at the beginning and did not converge (i.e., less than 5%) until the
number of cell across the gap was increased to six. Since both data do not change
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dramatically after the cells number reaches six, this setting became the finalized mesh
setup for Model 1.
Similarly, the rest of the models show decreasing trend on both data as the number
of the cells approaches to six. Therefore, six cells across the gap were applied to all the
model, and used as the finalized mesh setup.

Figure 37. Percent differences between current and successive mesh setup
in WSS magnitude on the tissue surface for each model.

Figure 38. Percent differences between current and successive mesh
setup in torque on the tissue for each model
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Mesh Properties
Mesh properties for each bioreactor model are reported in Table 12. These values
were obtained when the number of cell across the gap is equal to six. The aspect ratio is a
measure of the stretching of the cell. Ideal aspect ratio is when the value equals to 1.
Skewness is the evaluation of the shape of the cell, and it ranges from 0 to 1. The smaller
the value is means the better the cell quality is. The orthogonal quality and the overall
element quality were also analyzed, and they both range from 0 to 1 as well. However,
the larger the value is means the better the cell quality is.

Table 12. Mesh properties (n=6) for each bioreactor models
Model 1
Model 2
Model 3
Model 4
Model 5
Aspect Ratio
1.8394
1.8377
1.8367
1.8382
1.8387
Skewness
0.2195
0.2193
0.2194
0.2197
0.2201
Orthogonal Quality
0.7789
0.7791
0.7790
0.7790
0.7783
Element Quality
0.8412
0.8416
0.8417
0.8414
0.8412
Number of
9,371,027 11,025,837 13,646,156 13,564,437 17,414,200
Elements

5.3.2

Finalized Dimensions
The calculated results for NRMSD and R 2 in terms of WSS magnitude and

angular variation are listed in Table 13 and Table 15, respectively. The lower the
NRMSD and the greater the R 2 are obtained mean the closer the computed results are to
the target WSS. Based on the WSS magnitude results, increasing the radius of the
bioreactor and the tissue location by 20% and 50% did not show significant improvement
as compared with the original model. Increasing the radius of the bioreactor by 50% and
100% and keeping the tissue at its original location yielded similar results as compared to
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the original model; however, it did not significantly improve the % error.
The angular variation of the computed WSS on tissue surface was also examined
for each model. Based on the WSS angular variation results, Model 2 and 3 yielded
similar results in NRMSD and R 2 values. The NRMSD calculated from Model 4 and 5
were slightly greater than Model 1; however, the differences were not significant. In
other words, none of the models was able to demonstrate an improved WSS angular
variation results as compared to Model 1.
Since Model 1 generated the least NRMSD and the greatest R 2 values in WSS
magnitude, and no significant differences were found in WSS angular variations,
dimensions of the bioreactor were finalized based on Model 1.

Table 13. The calculated NRMSD and R 2 values in WSS magnitude for each model
Model No.

Description

NRMSD

R2

1

Original

5.66%

0.997

2

20%

6.59%

0.994

3

50%

8.66%

0.983

4

50%, original tissue location

5.77%

0.997

5

100%, original tissue location

6.43%

0.996
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Table 14. The calculated NRMSD and R 2 values in WSS angular variations for each
model

5.3.3

Model No.

Description

NRMSD

R2

1

Original

19.1%

0.920

2

20%

19.0%

0.922

3

50%

19.1%

0.923

4

50%, original tissue location

19.6%

0.920

5

100%, original tissue location

19.8%

0.920

Optimized WSS Waveform
The scaled (optimized) WSS magnitude input shown in Figure 32 from section

5.2.2 produced a WSS output as shown in Figure 39. To quantitively assess the
improvement, NRMSD and R 2 were calculated, and the results show significant
differences (NRMSD: decreased from 5.66% to 1.16%; R 2 increased from 0.997 to
0.998, respectively.)
The computed WSS angular variations shown in Figure 35 yielded a NRMSD and

R 2 value at 19.1% and 0.920, respectively. By adjusting the tissue rotation according to
scaled angular variation waveform shown in Figure 40, the results were improved to
1.1% and 0.999 for NRMSD and R 2 , respectively. This demonstrates that the bioreactor
is capable of replicating the desired WSS environment in term of the magnitude and
directionality.

74

Figure 39. Comparisons between target, the initial and the optimized
(post-correction) WSS magnitude

Figure 40. Comparisons between target, initial, scaled and optimized (postcorrection) WSS angle waveform
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5.3.4

Servo/Motor Selection
After the operating conditions were determined, the torque required to perform the

rotation of such waveform and its RMST were calculated. The selection of the motors
was then based on the RMST, the average rotating speed, the maximum rotating speed
and the peak torque, and the values were summarized in Table 15.
To select motors which are capable of performing this kind of rotation, the stall
torque, the rated speed, the maximum speed and the peak torque of the motor need to
match/ be greater than the calculated RMST, average rotating speed, maximum rotating
speed and peak torque, respectively. By comparing the motor specification from ParkerHannifin Corp., PM-FALR5AM8 were selected for the cone rotation and tissue mount
rotation, respectively.

Table 15. Motor specifications requirement for cone and tissue mount rotations
Cone Motor Specs
Average Speed
583.3
Max Speed
2323.6
Peak Torque
0.000315
RMST
0.0092

RPM
RPM
Nm
Nm

Tissue Mount Motor Specs
Average Speed
-1.2
Max Speed
62.8
Peak Torque
4.1E-06
RMST
0.00085

RPM
RPM
Nm
Nm

76

5.4

Summary
In Specific Aim 3, bioreactor CFD models with five different dimensions were

created. The WSS magnitude and directionality waveforms at the proximal convexity of
TAV AA obtained from Specific Aim 1 were considered as target, and they were
programmed for the cone and tissue rotations, respectively, for the simulation. The
predicted WSS from each model was compared with the target by calculating the
NRMSD and R 2 . Based on the results, Model 1, the bioreactor with original dimensions,
was selected.
The operating conditions for the original bioreactor was determined through the
waveform optimization process, and an optimized WSS input was generated. By
prescribing corresponding angular velocity of this optimized WSS input to the cone, the
WSS output was improved from 5.66% and 0.997 to 1.16% and 0.998 for the NRMSD
and R 2 , respectively.
Torque requirements were calculated based on the optimized WSS input and the
tissues rotation angular velocity. PM-FALR5AM8 (Parker-Hannifin Corp., Cleveland,
OH) was selected for the cone rotation and tissue mount rotation, respectively.
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CHAPTER 6:
SUMMARY

The objectives of this thesis were to quantify the multidirectional characteristics
of the WSS caused by BAVs in the AA and to design a device capable of subjecting
native aortic tissue to native BAV WSS magnitude and directionality. The results from
Specific Aim 1 demonstrated that BAVs not only generated elevated WSS magnitude in
the convexity of the proximal AA, those elevated WSS also oriented within a wider range
of angles as compared with TAV. A novel multidirectional fluid shear stress bioreactor
was then designed based on the principle of a cone-and-plate viscometer to subject aortic
tissue to TAV/ BAV multidirectional WSS environment. Rotating tissue mounts were
adapted into the design to achieve the desired WSS directionality, and the WSS
magnitude was achieved by rotating the cone. Bioreactor dimension analyses were
performed, and the operating conditions were determined through ANSYS CFX. CAD
drawings of the bioreactor were created, and the servo/ motors were selected based on the
results from the CFD analysis.
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CHAPTER 7:
DISCUSSION

7.1

Novelty of the Study

WSS Characterization
In this thesis, the multidirectional characteristics of the WSS in the AA caused by
BAVs were quantified, and the assessment was done computationally through valve-aorta
FSI models [43]. The WSS multidirectionality was quantified in terms of TSM, OSI and
transWSS. TSM and OSI were evaluated in global, and in both longitudinal and
circumferential directions. Although previous PC-MRI research has also studied the WSS
characteristics [13], [39], [41], [70], [75], some limitations existed. For instance, the
recruited samples sometimes involve aortic stenosis, aortic insufficiency, pre-existed
aortic dilation, aortic aneurysm and other factors which might have influences on the
flow characteristics [37], [41], [67]. Another limitation is the method which was used to
extract and analyze the data. Sometimes, the WSS data were extracted and averaged
along the entire lumen of the AA. The WSS at the convexity and the concavity, which
could be very different, were not distinguished [39], [75].
The first novelty of the study is the valve-aorta FSI models used in this thesis
which include four different aortic valve morphotypes, and they were connected to nondilated AA with same dimensions. In this way, morphotype-dependent WSS
characteristics, if any, would be identified. Other factors (i.e., age, pre-existed aortic
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dilation, aortic stenosis, etc.), which might affect the flow and WSS characteristics, thus
were excluded. Furthermore, the data were extracted and analyzed separately at the
proximal convexity and concavity of the AA in this thesis.
Although previous research has studied the helical flow pattern observed in the
BAV AA through quantifying the longitudinal and circumferential components, to the
best of authors knowledge, the multidirectionality of WSS was never quantified. The
second novelty of the study is the method proposed in Section 3.2.4. By using this
method, the angle distribution of the elevated WSS could be identified. WSS
multidirectinoality was demonstrated at the proximal convexity of all BAV aortas.

Multidirectional Fluid Shear Stress Bioreactor
The bioreactor designed in this thesis is able to subject time-dependent
multidirectional WSS to samples. To the best of author’s knowledge, this is the first time
a fluid shear stress bioreactor capable of replicating both time-varying WSS magnitude
and directionality introduced. As the interests in the effects of WSS directionality on
cardiovascular diseases (e.g., atherosclerosis, valvular diseases, aortopathy, etc.) have
risen, this design will be beneficial for elucidating the cause-and-effect relationship
between the WSS magnitude/ directionality and the relevant cardiovascular diseases.

7.2

WSS Characteristics in TAV/ BAVs Proximal AA

WSS Magnitude
In the proximal AA, all BAVs generated shear stress overload at the convexity,
with much of the dominant force occurring in the circumferential direction, and
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underload at the concavity as compared with TAV. This matched previous clinical
findings [75] and corresponded the asymmetric aortic dilation pattern found in BAV
patients [27], [54]. The varying magnitude of WSS are always morphotype-dependent,
and were shown to vary widely depending upon location. Among all BAV models, LRBAV generated the most severe time-averaged WSS overload at the convexity, and the
circumferential component was dominant in all BAV models. Previous clinical research
found that the aortic dilation in patients with LR-BAV morphotype is asymmetric and
prone to occur at the root and convexity of the AA, which were also the regions where
the highest WSS overload was observed in LR-BAV aorta model.

WSS Directionality
In the proximal convexity, TAV had the highest LOSI among all the models, and
the COSI were almost zero at the convexity for all the models. In the proximal concavity,
high LOSI were observed in all the models, as compared to the convexity in which high
COSI were also observed except for the TAV morphotype. Since the longitudinal TSM
was the dominant component at both convexity and concavity of the TAV AA plus high
LOSI and low COSI, this implied that TAV generated unidirectional flow at both regions.
In contrast, the circumferential TSM was the dominant component at the convexity of all
BAV AAs, and all BAVs exhibited almost zero COSI and non-zero LOSI. This implied
that although the flow seemed to be unidirectional along the circumferential direction.
Based off of this data, it could be assumed that the right-handed helical structure of the
flow is consistently maintained throughout the entire cardiac cycle, with slight flow
alterations in the longitudinal direction. Endothelial cells within this region, which
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experienced lower quantities of WSS and pulsatile flow with reversal in a normal TAV
morphotype, were now subjected to overloads within a relatively large range of angular
change. Since the flow was more complicated in BAV AAs as compared to TAV AA, and
the direction of the flow cannot be assessed simply by evaluating the OSI values.
To better evaluate the correlation between the WSS multidirectionality and aortic
dilation, other data must be considered. Based on the polar plots results, all BAV
demonstrate wider angle coverage with elevated WSS. Among all BAVs, RN-BAV has
the maximum WSS magnitude value, as well as threshold angular variation. This matches
the findings suggested in the previous research, where severe flow abnormalities were
observed in the AA of patients with this morphotype. Furthermore, patients presenting a
RN-BAV have been associated with a higher risk of obtaining aortic dilation [39].
TransWSS is the other index that was used to quantify the WSS
multidirectionality in this thesis. It was quantified based on both the magnitude and
angular deviation from the reference axis over a period of time. TransWSS can ranges
from 0 to its total TSM. The closer the value to the total TSM means the flow is more
multidirectional. Based on the results at the convexity in Figure 20, it showed that
multidirectional WSS was only presented in the TAV AA. This did not match our
findings from the polar plots, because this kind of quantification was case-dependent.
Instead of quantifying the WSS multidirectionality case by case, assessing it by making
the comparison based on one, normal case (i.e., TAV) will better identify the WSS
abnormalities in BAV cases.
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7.3

WSS Angular Deviation from the Circumferential Direction Computed on Tissue
Ideally, the shear stress on the tissue surface generated by the cone rotation is in

the circumferential direction. Based on the results from Specific Aim 3, angular deviation
was detected from the WSS exerted on the tissue. The discrepancy was observed during
systolic phase where the cone angular velocity reached its maximum value. This
suggested that the high rotating speed of the cone caused secondary flow effects in the
device. Theoretically, increasing the distance of the bioreactor wall from the center
should mitigate the secondary flow effects caused by the wall. However, based on the
results from Model 4 and 5 in Specific Aim 3, increasing the distance of the wall by 50%
and 100% did not improve the WSS orientation results.
To solve the problem of WSS angular deviation, two solutions were proposed.
The first solution is to reduce the cone angular velocity, if possible, to ensure the flow is
laminar and in the circumferential (i.e., keep Re  1 ). The second solution is taken from
the advantage of the rotating tissue mount. If the angular velocity prescribed for the cone
motion cannot be reduced, adjusting the tissue orientation and ensuring the tissue
alignment in the direction of the computed WSS will solve the problem.

7.4

Limitations of the Study
Although the design was verified to be capable of replicating the WSS magnitude

and directionality, limitation existed in the maximum allowable angular velocity
programmed for the cone rotation. As mentioned earlier, the Reynolds number must be
maintained at a very low value (i.e., Re  1 ) in order to keep the flow laminar in the
circumferential direction. The Reynolds number calculation for this device showed that
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the value increases as the cone angular velocity increases, and secondary flow effects
occurred. Based on the bioreactor dimensions and the fluid used in this study, the
maximum cone angular velocity allowed in order to have a laminar flow in the
circumferential direction was 89.97 rad/s. In other words, when the operating condition
for the cone rotation is below 89.97 rad/s., the fluid environment is considered as ideal. If
not, adjustments either on the cone or the tissue rotation will be required.

7.5

Clinical Implication
According to the discussion in the previous subsections, two key findings were

reported. First, WSS overload occurs at the convexity in all BAV models, and the most
unfavorable overload was found in the LR-BAV aorta model. Second, lower LOSI were
presented at the convexity of the BAV aorta models as compared with the TAV aorta
model, and low COSI presented at the convexity of the BAV aorta models relative to its
concavity. Furthermore, the WSS angle distribution of the elevated WSS at the convexity
is significant greater in all BAV AAs than TAV AA. Assessing the flow direction
through the values of LOSI and COSI alone did not provide a complete analysis, since
OSI does not account for WSS magnitude. Instead, to assess the changes in the flow
direction, one should first identify the elevated WSS magnitude and then quantify its
corresponding angle distribution.

7.6

Future Work
In this thesis, the CAD drawings were created, the operating conditions were
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determined, and the design was verified through CFD. The next step is to physically
fabricate the bioreactor and perform biological validation. After these are completed, the
bioreactor will be utilized in testing the hemodynamic theory of BAV aortopathy in vitro
and provide new insights into the aortic wall response to native BAV flow abnormalities.
Once the existence of the cause-and-effect relationships between native BAV
hemodynamics and aortic medial degeneration is demonstrated, the bioreactor will guide
the development of more effective therapeutic strategies for BAV arotopathy based on
flow normalization or pharmacological blocking of the flow-mediated biology.
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APPENDIX A: Time-varying WSS Vector in the Convexity of Proximal AA for All
Valve-aorta Models
Animation of the time-varying WSS vector was also provided as online supplementary
material.
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APPENDIX B: CAD Drawings of Each Bioreactor Part
The CAD drawings of each bioreactor part are shown in the following pages.
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